|Day Low/High||0.67 / 0.72|
|52 Wk Low/High||0.49 / 1.40|
Bioenvision and Langer sink after disappointing first-quarter reports.
Good trading does not have to equal long hours. Plus, charts of the SPY, Ryanair and more.
The company gets so-called orphan drug status for its anaplastic thyroid cancer drug.
Shares of the micro-cap have risen 1,669% in seven months, with little fundamental justification.
Equities rally in the final hour, while Alan Greenspan warns Congress about high energy prices.
The biotech company's shares rise 80%, and volume is extremely heavy.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.